Dyne Therapeutics to Present at November Investor Conferences
Dyne Therapeutics, Inc. (Nasdaq: DYN) will be presenting at two investor conferences in November, providing live webcasts and replays for 90 days.
11/07/2023 - 07:30 AM
WALTHAM, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that management is scheduled to present at the following investor conferences in November:
Stifel 2023 Healthcare Conference , fireside chat on Tuesday, November 14, 2023 at 4:45 p.m. ET in New York Piper Sandler 35th Annual Healthcare Conference , fireside chat on Tuesday, November 28, 2023 at 1:30 p.m. ET in New YorkA live webcast of each presentation will be available in the Investors & Media section of Dyne’s website at https://investors.dyne-tx.com/news-and-events/events-and-presentations and a replay will be accessible for 90 days.
About Dyne Therapeutics
Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com/ X LinkedIn Facebook
Contact:
Dyne Therapeuticsareilly@dyne-tx.com
What conferences will Dyne Therapeutics be presenting at in November 2023?
Dyne Therapeutics will be presenting at the Stifel 2023 Healthcare Conference and the Piper Sandler 35th Annual Healthcare Conference.
Where can I watch the presentations?
The presentations will be available via live webcast in the Investors & Media section of Dyne's website.
How long will the replays be accessible?
The replays will be accessible for 90 days after the presentations.
Dyne Therapeutics Inc
NASDAQ:DYN
DYN Rankings
#4413 Ranked by Stock Gains
DYN Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Tags
Commercial Services, Miscellaneous Commercial Services, Health Technology, Biotechnology
Country
US
City
Waltham
About DYN
dyne therapeutics, inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the united states. it develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its force platform that delivers disease-modifying therapies. the company was founded in 2017 and is based in waltham, massachusetts.
